
Lumiera Health Inc. Stock Analysis NHP.H.V
Lumiera Health, Inc. engages in the commercialization and development of evidence-based botanical products for the healthcare and bio-agriculture. The company is headquartered in Saint-Hubert, Quebec. The company went IPO on 2013-11-14. Through its Holizen Laboratories division, the Company offers a diverse portfolio of herbal tonics and natural supplements, including a line of sleep aids. Additionally, the Company is introducing a topical product line that targets the endocannabinoid system without using cannabis, providing a solution for chronic pain and inflammation. Its brands also include Awaye and Bazzzics. Awaye is a topical product that works with the body's own endocannibinoid pain defense system and provides relief from both acute and chronic pain. Part of the Holizen portfolio, Bazzzics is a line of three formulas composed of sedative plant extracts that can be combined to address the customer's specific sleeping needs: pre-sleep serenity, fall asleep, and stay asleep.
Read More Lumiera Health Inc (NHP.H.V) Chart
Key Statistics of Lumiera Health Inc (NHP.H.V)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.01Volume
292.00KP/E Ratio (TTM)
-Market Cap
850.00KAvg. Volume
716.00KDividend Yield
-Financial Metrics & Statements of Lumiera Health Inc (NHP.H.V)
FAQ's for Lumiera Health Inc (NHP.H.V)
- According to Musaffa’s Shariah screening methodology, Lumiera Health Inc (NHP.H.V) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.